1. Acar JF, Goldstein FW, Chabbert YA (1973) Synergistic activity of trimethoprim-sulphamethoxazole combination in Gram-negative bacilli. Observations in vitro and in vivo. J Infect Dis [Suppl] 128: 470–477
2. Acar JF, Goldstein FW, Gerbaud GR, Chabbert YA (1977) Plasmides de résistance au triméthoprime: transférabilité et groupes d’incompabilité. Ann Inst Pasteur (Paris) 128A: 41–47
3. Acar JF, Goldstein FW, Pinto ME, Then RL, Toivanen P (1980) Comparison of trimethoprim-resistant strains isolated from urinary tract infections in Finland and France. Proc 11 th ICC/19th ICAAC, Boston. In: Nelson, JD, Grassi C (eds) Current chemotherapy and infectious diseases. American Society for Microbiology, Washington, DC
4. Akiba T, Yokota T (1962) Studies on the mechanism of transfert of drug resistance in bacteria: 18: incorporation of 35 S sulphathiazole into cells of the multiple resistant strains and artificial sulfonamide-resistant strain of E. coli. Med Biol (Tokyo) 63: 155–159
5. Amyes SGB, Smith JT (1974a) R-factor trimethoprim resistance mechanism: an insusceptible target site. Biochem Biophys Res Commun 58: 412–418